Sunshine Biopharma (SBFM) Capital Expenditures (2015 - 2026)
Sunshine Biopharma's Capital Expenditures was $7,015 in Q2 2026, down 95.6% from $160,000 a year earlier but up 36.8% from the prior quarter.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Capital Expenditures (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Sunshine Biopharma's Capital Expenditures was $19,145 through Jun 30, 2026, down 97.6% year-over-year; for FY2025, it was $174,491, down 89.5% from FY2024.
- Capital Expenditures shows a five-year compound annual growth rate of 171.1% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $1.66 million in FY2024, $82,251 in FY2023 (-57.6%) and $193,982 in FY2022.
- Quarterly Capital Expenditures has moved between -$382,363 (Q4 2023) and $974,513 (Q2 2024) over five years.
- Per Business Quant data, SBFM's Capital Expenditures in the three quarters before Q2 2026 was $5,129 (Q1 2026), -$1,039 (Q4 2025) and $8,040 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Sunshine Biopharma | 1.12 Mn | -37.97 Mn | 2.43 Mn | 7,015.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7,015.00 |
| Mar 31, 2026 | 5,129.00 |
| Dec 31, 2025 | -1,039.00 |
| Sep 30, 2025 | 8,040.00 |
| Jun 30, 2025 | 160,000.00 |
| Mar 31, 2025 | 7,490.00 |
| Dec 31, 2024 | 102,600.00 |
| Sep 30, 2024 | 517,005.00 |
| Jun 30, 2024 | 974,513.00 |
| Mar 31, 2024 | 62,937.00 |
| Dec 31, 2023 | -382,363.00 |
| Sep 30, 2023 | 9,634.00 |
| Dec 31, 2022 | 193,982.00 |
| Dec 31, 2020 | 391.00 |
| Sep 30, 2020 | 800.00 |
| Dec 31, 2019 | 860.00 |
| Sep 30, 2019 | -485.00 |
| Jun 30, 2019 | 485.00 |
| Dec 31, 2018 | -8,520.00 |
| Sep 30, 2018 | 5,000.00 |
API Access
Sunshine Biopharma Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SBFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "SBFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SBFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();